Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Please help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Insiders and Berkshire Dump Johnson & Johnson JNJ Stock
Insider trading shows JNJ management selling and no buying for years and Berkshire dumped all of JNJ stock. Gee, wonder why? Maybe corruption, lawsuits, recalls and toxic products? Nah...

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, insider, trading, berkshire
Date Created/Edited: 2013, July 18
 

Most Recent Content....
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
I love this quote on the Securities and Exchange Commission Form 4 web page for Johnson & Johnson
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
Considering the SEC Form 4 shows that management is not buying JNJ stock, and has been selling since 2011, it seems like a very good indication that Johnson & Johnson executives are not very confident in the future of JNJ. In addition, Berkshire and Hathaway, the conglomerate holding company, has dropped Johnson & Johnson from their portfolio. Well, it's really starting to look like all the problems at Johnson & Johnson are finally affecting management and investor confidence in the company.
 
If you take a look at the SEC Form 4 for Johnson & Johnson, it is apparent that management across the board has been dumping JNJ stock without buying for almost two years. Executives from the Controller, to the CEO to the retired CEO,the management is pulling their money out of the company. Isn't that a 'bad thing'? In addition, unlike other, similar industries, insider trading is - $87,806,045.
 

Warren Buffett's Berkshire Hathaway started off in March 2012 with 30 million shares of JNJ. By June 30, 2012 had sold off almost one third of his JNJ stock. That seems like a lot to me. Berkshire continued to dump JNJ with dropping over 29 million shares of JNJ stock in less than a year. After dropping more than 95% of JNJ stock, the value of the stock they still hold makes up only $34 million of their multi-billion dollar portfolio. During the first quarter of 2013, Berkshire dumped the last of JNJ from Warren Buffet's portfolio.

 
Yep, looks like a whole lot of bailing going on, and we're not talking hay.
 
Maybe it is becoming apparent to Billy, Dorksky, Dominic, Russell, James, and Mr. Warren Buffet, that JNJ stock finally has more outgoing in recalls, litigation, settlements, fines, restituttion and lawsuits against it than Johnson & Johnson can handle with current income and cash reserves.
 
Wait, I think I saw that coming about a year ago - and a lot more have been added since then.
 
Resources:
1. US SEC (Current). SEC Form 4 Insider Trading United States Securities Exchange Commission. Retrieved from http://www.secform4.com/insider-trading/200406.htm
 
2. Jon C. Ogg (2013, May 13). Berkshire Hathaway 2013 Annual Meeting Focus: Buffett Portfolio Changes 24/7 Wall St.. Retrieved from http://247wallst.com/banking-finance/2013/05/03/berkshire-hathaway-2013-annual-meeting-focus-buffett-portfolio-changes/
 
3. Bloomberg News (2012, August 14). Buffett's Berkshire Hathaway cuts Johnson & Johnson holdings, adds oil NJ.com. Retrieved from http://www.nj.com/business/index.ssf/2012/08/buffetts_berkshire_hathaway_cu.html
 
4. Alex Crippen (2012, November 14). Buffett's Berkshire Sells Most of J&J and GE Stakes CNBC. Retrieved from http://www.cnbc.com/id/49827014
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries